- Jan. 10, 2022
-- he global Active Pharmaceutical Ingredients (API) Market was valued at USD 179.6 Billion in the year 2020. Growth opportunities for the Active Pharmaceutical Ingredient market is attributed to the growth of the geriatric population, rising technical advancements, increasing API manufacturing facilities in the world and increasing number of research and development activities by some of the key market players in the global platform.
Additionally, growing awareness, as well as investments in the development of new drugs in the market, is pushing the number of clinical trials in the world which is driving the Active Pharmaceutical Ingredient market. With the rising prevalence of respiratory diseases due to the outbreak of COVID-19, it is expected that there will be more demand for new drugs which is likely to push the demand for API and consequently affect the Global Active Pharmaceutical Market in the world.Scope of the Report
For more Information:https://azothanalytics.com/report/healthcare-and-pharmaceutical/global-active-pharmaceutical-ingredient-api-market-analysis-by-drug-type-generic-innovative-synthesis-synthetic-biotech-by-application-by-region-by-country-2021-edition-market-insights-and-forecast-with-impact-of-covid-19-2021-2026
- The report analyses the Active Pharmaceutical Ingredients Market by Value (USD Billion)
- The report analyses the Active Pharmaceutical Ingredients Market by Application (Oncology, Cardiology, Diabetes, Neurology, Others).
- The report analyses the Active Pharmaceutical Ingredients Market by Drug Type (Generic API, Innovative API)
- The report analyses the Active Pharmaceutical Ingredients Market by Synthesis (Synthetic, Biotech)
- The Global Active Pharmaceutical Ingredients Market has been analysed By Region (North America, Europe, Asia Pacific, LAMEA).
- The attractiveness of the market has been presented by region, by Application, by Drug Type and by Synthesis.
- The report tracks competitive developments, strategies, mergers and acquisitions and new product development.
- The companies analysed in the report include Pfizer Inc., GlaxoSmithKline, AbbVie Inc., Novartis AG, Eli Lilly and Company, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sanofi, Bristol-Myers Squibb and Boehringer Ingelheim.
- The report presents the analysis of the Active Pharmaceutical Ingredients market for the historical period of 2016-2020 and the forecast period of 2021-2026.
(Business Development Manager)
Address: CS - 55, Third Floor, Ansal Plaza,
Tel: +91-120- 4298235
Mail ID - firstname.lastname@example.org